Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease.

Szelechowski M, Bétourné A, Monnet Y, Ferré CA, Thouard A, Foret C, Peyrin JM, Hunot S, Gonzalez-Dunia D.

Nat Commun. 2014 Oct 21;5:5181. doi: 10.1038/ncomms6181.

PMID:
25333748
2.

Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.

Kim HG, Ju MS, Kim DH, Hong J, Cho SH, Cho KH, Park W, Lee EH, Kim SY, Oh MS.

Basic Clin Pharmacol Toxicol. 2010 Dec;107(6):958-64. doi: 10.1111/j.1742-7843.2010.00612.x.

3.

Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.

Salama M, Ellaithy A, Helmy B, El-Gamal M, Tantawy D, Mohamed M, Sheashaa H, Sobh M, Arias-Carrión O.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):836-43.

PMID:
23198691
4.

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.

Lee Y, Park HR, Chun HJ, Lee J.

J Neurosci Res. 2015 May;93(5):755-65. doi: 10.1002/jnr.23544. Epub 2015 Feb 9.

PMID:
25677261
5.

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.

Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A.

Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.

PMID:
21712347
6.

Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.

Li DW, Yao M, Dong YH, Tang MN, Chen W, Li GR, Sun BQ.

Int J Mol Med. 2014 Nov;34(5):1358-64. doi: 10.3892/ijmm.2014.1904. Epub 2014 Aug 19.

PMID:
25174304
7.
8.

The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.

Tseng YT, Chang FR, Lo YC.

Phytomedicine. 2014 Apr 15;21(5):724-33. doi: 10.1016/j.phymed.2013.11.001. Epub 2014 Jan 7.

PMID:
24411708
9.

Involvement of lysosomes in the early stages of axon degeneration.

Zheng J, Yan T, Feng Y, Zhai Q.

Neurochem Int. 2010 Feb;56(3):516-21. doi: 10.1016/j.neuint.2009.12.012. Epub 2009 Dec 28.

PMID:
20036294
10.

Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.

Kim S, Park SE, Sapkota K, Kim MK, Kim SJ.

J Pharm Pharmacol. 2011 Oct;63(10):1358-67. doi: 10.1111/j.2042-7158.2011.01342.x. Epub 2011 Aug 30.

PMID:
21899552
11.

Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model.

Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, Gorin F, Bharath MM.

Neuroscience. 2007 Nov 23;149(4):917-30. Epub 2007 Sep 12.

PMID:
17936517
12.

Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.

Ren Z, Yang N, Ji C, Zheng J, Wang T, Liu Y, Zuo P.

Neuropharmacology. 2015 Jun;93:209-18. doi: 10.1016/j.neuropharm.2015.01.030. Epub 2015 Feb 11.

PMID:
25680233
13.

Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.

Decressac M, Pain S, Chabeauti PY, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A.

Neurobiol Aging. 2012 Sep;33(9):2125-37. doi: 10.1016/j.neurobiolaging.2011.06.018. Epub 2011 Aug 3.

PMID:
21816512
14.

Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.

Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G.

Behav Brain Res. 2015 Mar 15;281:215-21. doi: 10.1016/j.bbr.2014.12.035. Epub 2014 Dec 23.

PMID:
25541039
15.

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.

Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P.

FASEB J. 2001 Jan;15(1):164-170.

PMID:
11149904
16.

Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease.

Filomeni G, Graziani I, De Zio D, Dini L, Centonze D, Rotilio G, Ciriolo MR.

Neurobiol Aging. 2012 Apr;33(4):767-85. doi: 10.1016/j.neurobiolaging.2010.05.021. Epub 2010 Jul 1.

PMID:
20594614
17.

The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons.

Cheng J, Wang F, Yu DF, Wu PF, Chen JG.

Eur J Pharmacol. 2011 Jan 10;650(1):184-94. doi: 10.1016/j.ejphar.2010.09.033. Epub 2010 Sep 21.

PMID:
20868662
18.

Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease.

Fiskum G, Starkov A, Polster BM, Chinopoulos C.

Ann N Y Acad Sci. 2003 Jun;991:111-9. Review.

PMID:
12846980
19.

Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.

Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J.

J Neurosci Res. 2010 Jul;88(9):1943-50. doi: 10.1002/jnr.22357.

PMID:
20143419
20.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810

Supplemental Content

Support Center